FibroGen
FGEN
FGEN
193 hedge funds and large institutions have $2.47B invested in FibroGen in 2018 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 64 increasing their positions, 63 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.12% more ownership
Funds ownership: 2.47% → 2.59% (+0.12%)
14% less call options, than puts
Call options by funds: $22.7M | Put options by funds: $26.4M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
193
Holding in Top 10
3
Calls
$22.7M
Puts
$26.4M
Top Buyers
| 1 | +$36.6M | |
| 2 | +$19.5M | |
| 3 | +$17.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$15.7M |
| 5 |
AG
Artal Group
Luxembourg
|
+$11.6M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$16.9M | |
| 3 | -$8.1M | |
| 4 |
Renaissance Technologies
New York
|
-$6.55M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$6.02M |